Tci Wealth Advisors, Inc. Ptc Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$38.16 - $48.86 $2,060 - $2,638	-54 Reduced 13.24%	354 $17,000
Q4 2022 Feb 06, 2023	BUY	$33.53 - $54.79 $2,782 - $4,547	83 Added 25.54%	408 $15,000
Q3 2022 Nov 08, 2022	BUY	$41.85 - $53.85 $41 - $53	1 Added 0.31%	325 $16,000
Q2 2022 Jul 19, 2022	BUY	$25.6 - $45.23 $8,294 - $14,654	324 New	324 $13,000
Q4 2021 Jan 24, 2022	SELL	$35.36 - $41.86 $6,895 - $8,162	-195 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$37.95 - $49.37 $3,795 - $4,937	100 Added 105.26%	195 $8,000
Q1 2021 Apr 29, 2021	BUY	$46.8 - $68.92 $4,446 - $6,547	95 New	95 $4,000
Q1 2020 Apr 14, 2020	SELL	$32.37 - $59.36 $841 - $1,543	-26 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$29.83 - $46.51 $775 - $1,209	26 New	26 $1,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.